[Eyes On] Fettered by accounting dispute, Samsung BioLogics faces first major challenge
IndustryMay 30, 2018
It all started with a command from the chairman who laid out the future of tech giant Samsung, the world’s largest chipmaker. Samsung Biopharma was one of the five new businesses that now-bedridden Chairman Lee Kun-hee came up with in 2010. But it was a mid-level salaryman who engineered the birth of Samsung’s biologics business and watched it grow. Samsung BioLogics CEO Kim Tae-han was one of many executives at Samsung’s now-defunct Corporate Strategy Office -- a control tower that orchestrated